UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
Breakthrough one-time cancer treatment option for select patients with metastatic melanoma and solid tumors now offered at UC San Diego Health.
School of Medicine
The Latest
Study: Surgical Intervention Improves Quality of Life for Patients with Acoustic Neuroma
UC San Diego School of Medicine study shows that an adanced, surgical technique to treat a benign brain tumor improves hearing, balance, and quality of life.
New ‘Atlas’ Provides Unprecedented Insights on How Genes Function in Early Embryo Development
UC San Diego biologists have provided new insights on a longstanding puzzle in biology: How complex organisms arise from a single fertilized cell. Producing a new “gene atlas” with 4D imaging, the researchers captured unprecedented insights on how embryonic development unfolds.
Nearly 3% of Healthy Adolescents use Commercial CBD Products, Study Finds
Researchers at UC San Diego have found that nearly 3% of healthy adolescents use commercial CBD products, many of which contain higher levels of THC than advertised.
NIH Awards Coast-To-Coast Consortium $5.6 Million for All of Us Research Program
Researchers at the University of California San Diego have been awarded a $5.6 million grant to further their efforts within the All of Us Research Program, which aims to accelerate and promote equity in health research.
Strategic Research Plan Refresh Looks to Evolve What UC San Diego Does Best
What broad and pressing societal problems, challenges or questions do you think UC San Diego is uniquely, well-positioned to help solve.
Trending Stories
In the Media
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
CNBC, March 24
UC San Diego researcher wins local Scientist of the Year award
The San Diego Union-Tribune, March 16
UCSD neurosurgeon rallies broad national support in fight to save research funding
The San Diego Union-Tribune, March 10
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
